These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8080889)

  • 1. Clozapine treatment and its effect on neuroendocrine responses induced by the serotonin agonist, m-chlorophenylpiperazine.
    Kahn RS; Davidson M; Siever LJ; Sevy S; Davis KL
    Biol Psychiatry; 1994 Jun; 35(12):909-12. PubMed ID: 8080889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haloperidol and clozapine treatment and their effect on M-chlorophenylpiperazine-mediated responses in schizophrenia: implications for the mechanism of action of clozapine.
    Kahn RS; Siever L; Davidson M; Greenwald C; Moore C
    Psychopharmacology (Berl); 1993; 112(1 Suppl):S90-4. PubMed ID: 7831445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin function and treatment response to clozapine in schizophrenic patients.
    Kahn RS; Davidson M; Siever L; Gabriel S; Apter S; Davis KL
    Am J Psychiatry; 1993 Sep; 150(9):1337-42. PubMed ID: 8394651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of olanzapine treatment on m-chlorophenylpiperazine-induced hormone release in schizophrenia.
    Scheepers FE; Gespen de Wied CC; Kahn RS
    J Clin Psychopharmacol; 2001 Dec; 21(6):575-82. PubMed ID: 11763004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia.
    Owen RR; Gutierrez-Esteinou R; Hsiao J; Hadd K; Benkelfat C; Lawlor BA; Murphy DL; Pickar D
    Arch Gen Psychiatry; 1993 Aug; 50(8):636-44. PubMed ID: 8343034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin function in schizophrenia: effects of meta-chlorophenylpiperazine in schizophrenic patients and healthy subjects.
    Kahn RS; Siever LJ; Gabriel S; Amin F; Stern RG; DuMont K; Apter S; Davidson M
    Psychiatry Res; 1992 Jul; 43(1):1-12. PubMed ID: 1332094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine response to meta-chlorophenylpiperazine and ipsapirone in relation to anxiety and aggression.
    Klaassen T; Riedel WJ; van Praag HM; Menheere PP; Griez E
    Psychiatry Res; 2002 Dec; 113(1-2):29-40. PubMed ID: 12467943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pindolol pretreatment blocks stimulation by meta-chlorophenylpiperazine of prolactin but not cortisol secretion in normal men.
    Meltzer HY; Maes M
    Psychiatry Res; 1995 Sep; 58(2):89-98. PubMed ID: 8570772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of alprazolam on increases in hormonal and anxiety levels induced by meta-chlorophenylpiperazine.
    Sevy S; Brown SL; Wetzler S; Kotler M; Molcho A; Plutchik R; van Praag HM
    Psychiatry Res; 1994 Sep; 53(3):219-29. PubMed ID: 7870844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of clozapine with the meta-chlorophenylpiperazine (mCPP) discriminative stimulus.
    Fiorella D; Rabin RA; Winter JC
    Life Sci; 1996; 58(24):PL353-8. PubMed ID: 8649203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MCPP challenge test in schizophrenia: hormonal and behavioral responses.
    Iqbal N; Asnis GM; Wetzler S; Kahn RS; Kay SR; van Praag HM
    Biol Psychiatry; 1991 Oct; 30(8):770-8. PubMed ID: 1751620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of m-chlorophenylpiperazine after intravenous and oral administration in healthy male volunteers: implication for the pharmacodynamic profile.
    Feuchtl A; Bagli M; Stephan R; Frahnert C; Kölsch H; Kühn KU; Rao ML
    Pharmacopsychiatry; 2004 Jul; 37(4):180-8. PubMed ID: 15467976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia.
    Krystal JH; Seibyl JP; Price LH; Woods SW; Heninger GR; Aghajanian GK; Charney DS
    Arch Gen Psychiatry; 1993 Aug; 50(8):624-35. PubMed ID: 8102048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects.
    Kahn RS; Wetzler S; Asnis GM; Kling MA; Suckow RF; van Praag HM
    Psychiatry Res; 1991 Apr; 37(1):25-34. PubMed ID: 1650487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects.
    Anand A; Charney DS; Delgado PL; McDougle CJ; Heninger GR; Price LH
    Am J Psychiatry; 1994 Nov; 151(11):1626-30. PubMed ID: 7943451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects.
    Seibyl JP; Krystal JH; Price LH; Woods SW; D'Amico C; Heninger GR; Charney DS
    Psychiatry Res; 1991 Sep; 38(3):227-36. PubMed ID: 1754635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans.
    Mueller EA; Murphy DL; Sunderland T
    Psychopharmacology (Berl); 1986; 89(3):388-91. PubMed ID: 3014595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeys.
    Aloi JA; Insel TR; Mueller EA; Murphy DL
    Life Sci; 1984 Apr; 34(14):1325-31. PubMed ID: 6708733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin dysregulation in adolescents with major depression: hormone response to meta-chlorophenylpiperazine (mCPP) infusion.
    Ghaziuddin N; King CA; Welch KB; Zaccagnini J; Weidmer-Mikhail E; Mellow AM; Ghaziuddin M; Greden JF
    Psychiatry Res; 2000 Sep; 95(3):183-94. PubMed ID: 10974357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ritanserin antagonism of m-chlorophenylpiperazine effects in neuroleptic-free schizophrenics patients: support for serotonin-2 receptor modulation of schizophrenia symptoms.
    Abi-Saab W; Seibyl JP; D'Souza DC; Karper LP; Gueorgueva R; Abi-Dargham A; Wong ML; Rajhans S; Erdos JP; Heninger GR; Charney DS; Krystal JH
    Psychopharmacology (Berl); 2002 Jun; 162(1):55-62. PubMed ID: 12107618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.